News

Healthcare comms professionals: good times or hard times?

“Pharmaceutical companies have never had it so good”, argues FT columnist Brooke Masters, pointing to the sector’s sudden PR rehabilitation, riding a wave of vaccine goodwill. But as the current debate over the Oxford/AstraZeneca vaccine’s safety neatly illustrates: public trust can be eroded far more quickly than it can be won. For in-house comms teams […]

Read more

From highlighting the technology leading us out of the pandemic and announcing latest launches to creating noise ar… https://t.co/HlRD4NZ6hO
@kaizo_pr